EconPapers    
Economics at your fingertips  
 

Bargaining and International Reference Pricing in the Pharmaceutical Industry

Pierre Dubois, Ashvin Gandhi and Shoshana Vasserman
Additional contact information
Ashvin Gandhi: UCLA Anderson School of Management

Research Papers from Stanford University, Graduate School of Business

Abstract: The United States spends twice as much per person on pharmaceuticals as European countries, in large part because prices are much higher in the US. This fact has led policymakers to consider legislation for price controls. This paper assesses the effects of a US international reference pricing policy that would cap prices in US markets by those offered in reference countries. We estimate a structural model of demand and supply for pharmaceuticals in the US and reference countries like Canada where prices are set through a negotiation process between pharmaceutical companies and the government. We then simulate the counterfactual equilibrium under such international reference pricing rules, allowing firms to internalize the cross-country externalities introduced by these policies. We find that in general, these policies would result in much smaller price decreases in the US than price increases in reference countries. The magnitude of these effects depends on the number, size and market structure of references countries. We compare these policies with a direct bargaining on prices in the US.

JEL-codes: C51 C57 I11 I18 L11 L13 L22 (search for similar items in EconPapers)
Date: 2022-04
New Economics Papers: this item is included in nep-com and nep-reg
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.gsb.stanford.edu/faculty-research/work ... rmaceutical-industry

Related works:
Working Paper: Bargaining and International Reference Pricing in the Pharmaceutical Industry (2022) Downloads
Working Paper: Bargaining and International Reference Pricing in the Pharmaceutical Industry (2022) Downloads
Working Paper: Bargaining and International Reference Pricing in the Pharmaceutical Industry (2022) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ecl:stabus:3889

Access Statistics for this paper

More papers in Research Papers from Stanford University, Graduate School of Business Contact information at EDIRC.
Bibliographic data for series maintained by ().

 
Page updated 2025-03-30
Handle: RePEc:ecl:stabus:3889